P. Rayman

E. Klein, J. Finke, P. Rayman, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways1

J. Finke, C. Tannenbaum, T. Das, 2008, The Journal of Immunology.

Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.

J. Finke, C. Tannenbaum, P. Rayman, 2003, Cancer research.

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

B. Rini, J. Finke, P. Rayman, 2009, Clinical Cancer Research.

Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells.

B. Williams, J. Finke, P. Rayman, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.

A. Khorana, B. Hobbs, J. Barnard, 2021, Med.

Alterations in T-Cell Signaling Pathways and Increased Sensitivity to Apoptosis

I. Derweesh, T. Olencki, J. Finke, 2004 .

Mechanisms of immune dysfunction in renal cell carcinoma.

I. Derweesh, J. Finke, C. Tannenbaum, 2003, Cancer treatment and research.

CarcinomasExpressed on Renal Cell B in T Cells by κ Degradation of NF

I. Derweesh, C. Tannenbaum, P. Rayman, 2013 .

Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas1

I. Derweesh, J. Finke, C. Tannenbaum, 2004, The Journal of Immunology.

Carcinomas Gangliosides Expressed on Renal Cell B in T Cells by κ Degradation of NF-Finke

I. Derweesh, J. Finke, C. Tannenbaum, 2004 .

Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis

J. Finke, P. Rayman, M. Montano, 2012, Oncogene.

Alterations in NFκB Activation in T Lymphocytes of Patients With Renal Cell Carcinoma

A. Novick, R. Uzzo, J. Finke, 1999 .

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.

G. T. Budd, T. Olencki, A. Novick, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impaired Activation of NFκB in T Cells From a Subset of Renal Cell Carcinoma Patients Is Mediated by Inhibition of Phosphorylation and Degradation of the Inhibitor, IκB

A. Novick, R. Uzzo, J. Finke, 1998 .

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

N. Bander, A. Novick, R. Uzzo, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.

B. Rini, S. Campbell, J. Finke, 2018, Urologic oncology.

Myeloid-derived Suppressor Cells Adhere to Physiologic STAT3- vs STAT5-dependent Hematopoietic Programming, Establishing Diverse Tumor-Mediated Mechanisms of Immunologic Escape

B. Rini, J. Finke, P. Rayman, 2012, Immunological investigations.

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma

J. Weiss, W. Linehan, B. Rini, 2022, Frontiers in Oncology.

Associated with T Cell Dysfunction Cells from Renal Cell Carcinoma Patients Is Elevated Levels of Select Gangliosides in T

B. Rini, C. Tannenbaum, S. Ghosh, 2013 .

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

B. Rini, J. Finke, P. Rayman, 2011, International immunopharmacology.

Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction1

B. Rini, J. Finke, C. Tannenbaum, 2009, The Journal of Immunology.

Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion

William A. Flavahan, Qiulian Wu, R. Ransohoff, 2016, Stem cells.

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

G. T. Budd, J. Finke, P. Rayman, 1991, Cancer research.

Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer

S. Hazen, A. Tall, P. Rayman, 2017, Oncotarget.

University of Groningen Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer Zamanian-Daryoush,

S. Hazen, A. Tall, P. Rayman, 2017 .

The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects*♦

Stanley L Hazen, Patricia Parsons-Wingerter, S. Hazen, 2013, The Journal of Biological Chemistry.

Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

J. Finke, V. Tuohy, P. Rayman, 2014, International journal of cancer.

Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

B. Rini, J. Finke, M. Ernstoff, 2018, Targeted Oncology.

Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection

P. Rayman, G. Sen, C. Bergmann, 2020, PLoS pathogens.

Inhibition of NF-κB Activity in Human T Lymphocytes Induces Caspase-Dependent Apoptosis Without Detectable Activation of Caspase-1 and -3

J. Finke, P. Rayman, R. Bukowski, 1999, The Journal of Immunology.

GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway

J. Finke, C. Tannenbaum, T. Das, 2015, PloS one.

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.

A. Novick, J. Finke, C. Tannenbaum, 2006, Cancer research.

Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses

A. Novick, J. Finke, C. Tannenbaum, 2004, Clinical Cancer Research.

Clinical Results and Characterization of Tumor-infiltrating Lymphocytes with or without Recombinant Interleukin 2 in Human Metastatic Renal Cell Carcinoma 1

J. Finke, P. Rayman, R. Bukowski, 2006 .

Caspase-1 and-3 Apoptosis Without Detectable Activation of Lymphocytes Induces Caspase-Dependent B Activity in Human T κ Inhibition of NF

J. Finke, P. Rayman, R. Bukowski, 1999 .

Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.

J. Ritz, A. Novick, J. Finke, 1997, Journal of immunology.

TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.

J. Finke, C. Tannenbaum, T. Das, 2007, Journal of immunology.

The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis.

John C. Thomas, J. Finke, C. Tannenbaum, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Receptor-Independent Pathways Apoptosis through Receptor-Dependent and Renal Cell Carcinoma Tumors Induce T Cell

J. Finke, C. Tannenbaum, T. Das, 2008 .

Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.

T. Olencki, J. Finke, P. Rayman, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.

B. Rini, J. Finke, C. Tannenbaum, 2009, Cancer research.

The Differential Regulation of Human ACT1 Isoforms by Hsp90 in IL-17 Signaling

J. Casanova, J. Finke, P. Rayman, 2014, The Journal of Immunology.

Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade

A. Khorana, P. Rayman, S. Kundu, 2019, Blood.

Immune Checkpoint Inhibitors (ICI) Enhance Cancer Associated Thrombosis (CAT) in Murine Model of Colon Carcinoma

A. Khorana, P. Rayman, K. McCrae, 2021, Blood.

Neoadjuvant durvalumab +/- tremelimumab affects the expression of immune checkpoint (IC) molecules on myeloid derived suppressor cells (MDSC) in patients (pts) with locally advanced renal cell carcinoma (RCC).

B. Rini, P. Rayman, Jorge A. Garcia, 2019, Journal of Clinical Oncology.

Ifit2 restricts murine coronavirus spread to the spinal cord white matter and its associated myelin pathology

P. Rayman, G. Sen, C. Bergmann, 2023, Journal of virology.

The myeloid receptor TREM2 exacerbates DSS-induced colitis and promotes colitis-associated cancer (TUM4P.916)

W. Linehan, B. Rini, J. Finke, 2014, Journal of Immunology.

Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.

T. Olencki, A. Novick, J. Finke, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

C. Tannenbaum, P. Rayman, P. Pavicic, 2023, Oncoimmunology.

Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.

A. Novick, R. Uzzo, J. Finke, 2000, The cancer journal from Scientific American.

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model

B. Rini, J. Finke, P. Rayman, 2015, Journal of Immunotherapy for Cancer.

Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.

A. Novick, J. Finke, P. Rayman, 1999, Journal of immunotherapy.

Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

I. Derweesh, J. Finke, C. Tannenbaum, 2004, Journal of immunology.

Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5

Y. Najjar, B. Rini, J. Finke, 2014, Journal of Immunotherapy for Cancer.

GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial

J. Finke, P. Rayman, L. Rybicki, 2001, Journal of Cancer Research and Clinical Oncology.

Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells.

J. Finke, P. Rayman, M. Behlke, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Sunitinib's effect on tumor infiltration of CD8 T cells in renal cell carcinoma (RCC) and modulation of their function by altering VEGF-induced upregulation of PD1 expression.

B. Rini, J. Finke, P. Rayman, 2016 .